BlackRock Inc. - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 1.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,693,651
-64.3%
2,206,510
-3.8%
0.00%
-100.0%
Q2 2023$24,381,711
+58.6%
2,293,670
+24.3%
0.00%
Q1 2023$15,372,972
-9.0%
1,845,495
+0.8%
0.00%
-100.0%
Q4 2022$16,896,872
-22.9%
1,830,647
+7.2%
0.00%0.0%
Q3 2022$21,920,000
-2.5%
1,707,203
+0.3%
0.00%0.0%
Q2 2022$22,487,000
-24.9%
1,702,289
+19.7%
0.00%0.0%
Q1 2022$29,942,000
-15.8%
1,422,352
-4.0%
0.00%0.0%
Q4 2021$35,559,000
-1.1%
1,482,265
+4.9%
0.00%0.0%
Q3 2021$35,949,000
-29.5%
1,413,118
-6.8%
0.00%0.0%
Q2 2021$51,009,000
-20.9%
1,515,439
-8.7%
0.00%
-50.0%
Q1 2021$64,480,000
-37.3%
1,660,112
+0.0%
0.00%
-33.3%
Q4 2020$102,807,000
+148.3%
1,660,060
+34.3%
0.00%
+50.0%
Q3 2020$41,400,000
+43.1%
1,236,216
+1.8%
0.00%
+100.0%
Q2 2020$28,932,000
-7.8%
1,214,130
-11.4%
0.00%
-50.0%
Q1 2020$31,391,000
+20.6%
1,370,786
+49.1%
0.00%
+100.0%
Q4 2019$26,038,000
+95.8%
919,423
+48.6%
0.00%0.0%
Q3 2019$13,298,000
+898.3%
618,760
+1255.4%
0.00%
Q2 2019$1,332,00045,6510.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$562,187,00075.80%
RTW INVESTMENTS, LP 3,544,248$118,697,0002.86%
Cormorant Asset Management, LP 1,537,807$51,501,0001.98%
Redmile Group, LLC 2,549,506$85,383,0001.57%
Birchview Capital, LP 40,000$1,340,0000.45%
HighVista Strategies LLC 17,082$572,0000.42%
Perceptive Advisors 671,978$22,505,0000.33%
GILDER GAGNON HOWE & CO LLC 1,490,153$49,905,0000.31%
Artal Group S.A. 270,750$9,067,0000.22%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 323$11,0000.20%
View complete list of STOKE THERAPEUTICS INC shareholders